AIMS/HYPOTHESIS: The appearance of autoantibodies (Abs) before diabetes onset has mainly been studied in young children. However, most patients develop type 1 diabetes after the age of 15 years. In first-degree relatives aged under 40 years, we investigated the frequency of seroconversion to (persistent) Ab positivity, progression to diabetes and baseline characteristics of seroconverters according to age. METHODS: Abs against insulin (IAA), glutamate decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A) and zinc transporter 8 (ZnT8A) were measured during follow-up of 7,170 first-degree relatives. RESULTS: We identified 379 (5.3%) relatives with positivity for IAA, GADA, IA-2A and/or ZnT8A (Ab(+)) at first sampling and 224 (3.1%) at a later time point. Most seroconversions occurred after the age of 10 years (63%). During follow-up, Abs persisted more often in relatives initially Ab(+) (76%) than in seroconverters (53%; p < 0.001). In both groups diabetes developed at a similar pace and almost exclusively with Ab persistence (136 of 139 prediabetic individuals). For both groups, progression was more rapid if Abs appeared before the age of 10 years. Baseline characteristics at seroconversion did not vary significantly according to age. CONCLUSIONS/ INTERPRETATION: Seroconversion to (persistent) Ab(+) occurs regardless of age. Although the progression rate to diabetes is higher under age 10 years, later seroconverters (up to age 40 years) have similar characteristics when compared with age-matched initially Ab(+) relatives and generate an important minority of prediabetic relatives, warranting their identification and, eventually, enrolment in prevention trials.
AIMS/HYPOTHESIS: The appearance of autoantibodies (Abs) before diabetes onset has mainly been studied in young children. However, most patients develop type 1 diabetes after the age of 15 years. In first-degree relatives aged under 40 years, we investigated the frequency of seroconversion to (persistent) Ab positivity, progression to diabetes and baseline characteristics of seroconverters according to age. METHODS: Abs against insulin (IAA), glutamate decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A) and zinc transporter 8 (ZnT8A) were measured during follow-up of 7,170 first-degree relatives. RESULTS: We identified 379 (5.3%) relatives with positivity for IAA, GADA, IA-2A and/or ZnT8A (Ab(+)) at first sampling and 224 (3.1%) at a later time point. Most seroconversions occurred after the age of 10 years (63%). During follow-up, Abs persisted more often in relatives initially Ab(+) (76%) than in seroconverters (53%; p < 0.001). In both groups diabetes developed at a similar pace and almost exclusively with Ab persistence (136 of 139 prediabetic individuals). For both groups, progression was more rapid if Abs appeared before the age of 10 years. Baseline characteristics at seroconversion did not vary significantly according to age. CONCLUSIONS/ INTERPRETATION: Seroconversion to (persistent) Ab(+) occurs regardless of age. Although the progression rate to diabetes is higher under age 10 years, later seroconverters (up to age 40 years) have similar characteristics when compared with age-matched initially Ab(+) relatives and generate an important minority of prediabetic relatives, warranting their identification and, eventually, enrolment in prevention trials.
Authors: Bart J Van der Auwera; Frans C Schuit; Ilse Weets; Ann Ivens; Jan E Van Autreve; Frans K Gorus Journal: Hum Immunol Date: 2002-01 Impact factor: 2.850
Authors: K Decochez; I H De Leeuw; B Keymeulen; C Mathieu; R Rottiers; I Weets; E Vandemeulebroucke; I Truyen; L Kaufman; F C Schuit; D G Pipeleers; F K Gorus Journal: Diabetologia Date: 2002-11-12 Impact factor: 10.122
Authors: P Achenbach; V Lampasona; U Landherr; K Koczwara; S Krause; H Grallert; C Winkler; M Pflüger; T Illig; E Bonifacio; A G Ziegler Journal: Diabetologia Date: 2009-07-10 Impact factor: 10.122
Authors: T Kimpimäki; A Kupila; A M Hämäläinen; M Kukko; P Kulmala; K Savola; T Simell; P Keskinen; J Ilonen; O Simell; M Knip Journal: J Clin Endocrinol Metab Date: 2001-10 Impact factor: 5.958
Authors: Janet M Wenzlau; Lisa M Frisch; Thomas J Gardner; Suparna Sarkar; John C Hutton; Howard W Davidson Journal: Curr Diab Rep Date: 2009-04 Impact factor: 4.810
Authors: D Jacobs-Tulleneers-Thevissen; M Chintinne; Z Ling; P Gillard; L Schoonjans; G Delvaux; B L Strand; F Gorus; B Keymeulen; D Pipeleers Journal: Diabetologia Date: 2013-04-26 Impact factor: 10.122
Authors: E Mbunwe; B J Van der Auwera; I Weets; P Van Crombrugge; L Crenier; M Coeckelberghs; N Seret; K Decochez; E Vandemeulebroucke; P Gillard; B Keymeulen; C van Schravendijk; J M Wenzlau; J C Hutton; D G Pipeleers; F K Gorus Journal: Diabetologia Date: 2013-05-28 Impact factor: 10.122
Authors: F K Gorus; E V Balti; I Vermeulen; S Demeester; A Van Dalem; O Costa; H Dorchy; S Tenoutasse; T Mouraux; C De Block; P Gillard; K Decochez; J M Wenzlau; J C Hutton; D G Pipeleers; I Weets Journal: Clin Exp Immunol Date: 2013-01 Impact factor: 4.330
Authors: Eric Mbunwe; Bart J Van der Auwera; Ilse Vermeulen; Simke Demeester; Annelien Van Dalem; Eric V Balti; Sara Van Aken; Luc Derdelinckx; Harry Dorchy; Jean De Schepper; Chris van Schravendijk; Janet M Wenzlau; John C Hutton; Daniël Pipeleers; Ilse Weets; Frans K Gorus Journal: Diabetes Date: 2012-11-16 Impact factor: 9.461
Authors: Elin Pettersen Sørgjerd; Per M Thorsby; Peter A Torjesen; Frank Skorpen; Kirsti Kvaløy; Valdemar Grill Journal: BMJ Open Diabetes Res Care Date: 2015-06-25
Authors: Katrien Benhalima; Paul Van Crombrugge; Johan Verhaeghe; Sofie Vandeginste; Hilde Verlaenen; Chris Vercammen; Els Dufraimont; Christophe De Block; Yves Jacquemyn; Farah Mekahli; Katrien De Clippel; Roland Devlieger; Chantal Mathieu Journal: BMC Pregnancy Childbirth Date: 2014-07-11 Impact factor: 3.007
Authors: Olov Rolandsson; Christiane S Hampe; Stephen J Sharp; Eva Ardanaz; Heiner Boeing; Guy Fagherazzi; Francesca Romana Mancini; Peter M Nilsson; Kim Overvad; Maria-Dolores Chirlaque; Miren Dorronsoro; Marc J Gunter; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Vittorio Krogh; Tilman Kühn; Domenico Palli; Salvatore Panico; Carlotta Sacerdote; Maria-José Sánchez; Gianluca Severi; Annemieke M W Spijkerman; Rosario Tumino; Yvonne T van der Schouw; Elio Riboli; Nita G Forouhi; Claudia Langenberg; Nicholas J Wareham Journal: Diabetologia Date: 2019-11-11 Impact factor: 10.122